홈 › 유방암 › 펜실베이니아

펜실베이니아의 유방암 임상 시험

유방암 관련 연구 93개가 펜실베이니아 내 여러 지역에서 참여자를 모집하고 있습니다.

펜실베이니아의 도시

공식 연구 텍스트(영어)

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Penn State Milton S. Hershey Medical Center, Hershey

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT06324357

A Pilot Study Assessing Myokines During an EXErcise Regimen After Treatment for Breast Cancer

AHN Allegheny General Hospital, Pittsburgh
Allegheny General Hospital, Pittsburgh

피험자 모집 중

20세 ~ 89세 · 여성 · 2026. 9. 30. 업데이트됨 · NCT07698314

Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning

Allegheny General Hospital, Pittsburgh

피험자 모집 중관찰 연구

20세 ~ 89세 · 여성 · 2026. 9. 30. 업데이트됨 · NCT07023887

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

Research Site, Pittsburgh

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT05877599

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Consultants In Med Onco And Hema, Drexel Hill
Univ of Pittsburg Med Ctr Pinnacle, Harrisburg
Allegheny Health Network, Pittsburgh

피험자 모집 중3상

18세 ~ 100세 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT05827081

Study of AVZO-021 in Patients With Advanced Solid Tumors

Avenzo Therapeutics Recruiting Site, Philadelphia

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT05867251

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

University of Pittsburgh Medical Center Magee-Womens Hospital ( Site 0058), Pittsburgh
Cancer Care Associates Of York ( Site 0063), York

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07060807

EXERT-BC Protein: Protein Supplementation to Improve Body Composition After Treatment for Breast Cancer

AHN Allegheny General Hospital, Pittsburgh
AHN Allegheny General Hospital, Pittsburgh

피험자 모집 중

20세 ~ 89세 · 여성 · 2026. 9. 28. 업데이트됨 · NCT07704476

Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy

University of Pittsburgh Cancer Institute (UPCI), Pittsburgh

피험자 모집 중

30세 이상 · 여성 · 2026. 9. 25. 업데이트됨 · NCT02945579

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Penn Medicine - Lancaster General Hospital, Lancaster
Capital Health Hematology Oncology Specialists, Newton
Penn Medicine - Perelman Center for Advanced Medicine, Philadelphia
외 2개

피험자 모집 중3상

60세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06377852

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Thomas Jefferson University - Clinical Research Institute ( Site 0056), Philadelphia

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06312176

Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer

Clinical Trial Site, Horsham
Clinical Trial Site, Sayre

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07085767

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Allegheny (AHN), Pittsburgh

피험자 모집 중

18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07214532

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

University of Pennsylvania, Philadelphia
Fox Chase Cancer Center, Philadelphia

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07213791

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

St. Luke's University Health Network, Bethlehem
Lancaster General Hospital - Ann B Barshinger Cancer Institute, Lancaster
University of Pennsylvania Hospital, Philadelphia
외 3개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07174336

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

University of Pittsburgh Medical Center, Pittsburgh

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07114601

Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

University of Pennsylvania/Abramson Cancer Center, Philadelphia

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT07340541

Identifying Patterns in the Breath of Individuals With Breast Cancer

Weinstein Imaging Associates, Pittsburgh

피험자 모집 중관찰 연구건강한 지원자 환영

40세 ~ 74세 · 여성 · 2026. 9. 18. 업데이트됨 · NCT06512350

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Abramson Cancer Center of the University of Pennsylvania, Philadelphia
University of Pittsburgh Medical Center, Pittsburgh
WellSpan York Cancer Center, York

피험자 모집 중1/2상

12세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT04585750

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Lehigh Valley Health Network - Cedar Crest, Allen
Consultants In Medical Oncology and Hematology, P.C., Broomall
Penn State Milton S. Hershey Medical Center, Hershey
외 5개

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT06492616

Active Surveillance in Older Women With ER+ Breast Cancer

University of Pittsburgh Medical Center, Pittsburgh

피험자 모집 중관찰 연구

70세 이상 · 여성 · 2026. 9. 11. 업데이트됨 · NCT07262138

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Research Site, Pittsburgh

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT05123482

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

St. Luke's University Health Network, Bethlehem
Guthrie Medical Group, Sayre

피험자 모집 중1상

18세 ~ 55세 · 여성 · 2026. 9. 9. 업데이트됨 · NCT07310420

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

Penn State Health Milton S. Hershey Medical Center, Hershey
University of Pennsylvania - Abramson Cancer Center, Philadelphia
UPMC - Hillman Cancer Center, Pittsburgh

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 8. 업데이트됨 · NCT07100106

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

University of Pennsylvania, Philadelphia

피험자 모집 중1/2상

18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT05315700

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

UPMC Hillman Cancer Center - Magee-Women?s Hospital, Pittsburgh

피험자 모집 중3상

18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06790693

Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers

Penn State Cancer Institute, Hershey

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT04886531

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

Abramson Cancer Center, Philadelphia

피험자 모집 중관찰 연구

18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT05964504

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT07216105

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Lehigh Valley Hospital-Cedar Crest, Allentown
Lehigh Valley Hospital - Muhlenberg, Bethlehem
Geisinger Medical Center, Danville
외 7개

피험자 모집 중관찰 연구건강한 지원자 환영

40세 ~ 75세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT05334069

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Lehigh Valley Hospital-Cedar Crest, Allentown
Lehigh Valley Hospital - Muhlenberg, Bethlehem
Bryn Mawr Hospital, Bryn Mawr
외 56개

피험자 모집 중3상

18세 ~ 60세 · 여성 · 2026. 9. 2. 업데이트됨 · NCT05879926

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

UPMC Hillman Cancer Center, Pittsburgh

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT07029399

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

Sidney Kimmel Comprehensive Center at Jefferson, Philadelphia
UPMC, Pittsburgh

피험자 모집 중1상

18세 이상 · 모든 성별 · 2026. 8. 21. 업데이트됨 · NCT06774963

Biennial CEM in Women With a Personal History of Breast Cancer

UPMC Magee-Womens Imaging - Bethel Park, Bethel Park
UPMC Magee at the Lemieux Sports Complex, Cranberry Township
Magee Womancare Monroeville, Monroeville
외 3개

피험자 모집 중건강한 지원자 환영

30세 ~ 79세 · 여성 · 2026. 8. 19. 업데이트됨 · NCT06105749

ATEMPT 2.0: Adjuvant T-DM1 vs TH

University of Pennsylvania, Abramson Cancer Center, Philadelphia
University of Pittsburgh Medical Center Cancer UPMC- Magee Women's Hospital, Pittsburgh

피험자 모집 중2상

18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT04893109

PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

피험자 모집 중

18세 이상 · 모든 성별 · 2026. 8. 19. 업데이트됨 · NCT02732171

EXERT-BC Cardio: Cardio or Conditioning Training With Breast Cancer

AHN Allegheny General Hospital, Pittsburgh

피험자 모집 중

20세 ~ 89세 · 여성 · 2026. 8. 17. 업데이트됨 · NCT07739563

Tai Chi for Reducing Aromatase Inhibitor-Induced Arthralgia

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia

피험자 모집 중

18세 이상 · 여성 · 2026. 8. 14. 업데이트됨 · NCT07737951

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

Lehigh Valley Health Network, Allentown
Abramson Cancer Center of The University of Pennsylvania, Philadelphia
Local Institution - 0360, Pittsburgh

피험자 모집 중2/3상

18세 이상 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT06926868

Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery

Fox Chase Cancer Center, Philadelphia

피험자 모집 중

18세 이상 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT07140172

ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.